Clinical Characteristics and Prognosis of Pediatric Idiopathic Multicentric Castleman Disease
- 3 January 2025
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 100 (3) , 539-541
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Idiopathic multicentric Castleman disease (iMCD)‐idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD‐not otherwise specified with different clinical features and better survivalBritish Journal of Haematology, 2024
- Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman diseaseHaematologica, 2024
- Clinical Characteristics and Treatment Outcomes of Idiopathic Multicentric Castleman Disease: Data from a Pediatric CohortBlood, 2023
- International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseBlood, 2018
- International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman diseaseBlood, 2017
- Idiopathic multicentric Castleman's disease: a systematic literature reviewThe Lancet Haematology, 2016